Beacon Pharmaceuticals Ltd.
Additional OffersShow all
Mirogabalin may cause excessive drowsiness with alcohol.
There is no information available on the safety profile on using in pregnancy.
There is no information available on the safety profile on using in lactation.
Mirogabalin may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Mirogabalin should be used with caution in patients with kidney disease. Dose adjustment of Mirogabalin may be needed. Please consult your doctor.
Mirogabalin is safe to use in patients with liver disease. No dose adjustment of Mirogabalin is recommended.
Dosage & Administration
Normally, the initial dose for adults is 5 mg of Mirogabalin given orally twice daily, and then the dose is gradually increased by 5 mg at an interval o... View More
Mirogabalin does not induce or inhibit cytochrome P450 isoenzymes. Coadministration of Mirogabalin with Cimetidine or Probenecid may raise the Mirogabal... View More
Mirogabalin is contraindicated in: patients with hypersensitive to Mirogabalin. patients with mild to moderate Hepatic & Renal impairment.
The most reported adverse reactions include somnolence, dizziness, edema and weight gain. The symptoms described below are rarely seen as initial sympto... View More
Precautions & Warnings
This medicine may cause dizziness, somnolence, or loss of consciousness. Avoid operating dangerous machinery, such as driving a car. Especially for elde... View More
Store at below 30°C and dry place, away from light and moisture. Keep out of the reach of children.
Mirogabalin Besylate is indicated for the treatment of- Neuropathic Pain, Diabetic peripheral neuropathic pain (DPNP), Postherpetic neuralgia (PHN), Per... View More
Mirogabalin has selective and potent binding affinities for human α2δ subunits of VGCCs, which reduce calcium (Ca2+) influx and neurotransmission in DRG... View More
Alternative brand for Mirogab 10
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More